Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.13 +0.12 (+2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Non-Current Deferred Tax Liability (2021 - 2023)

Updated

Adial Pharmaceuticals (ADIL) recorded Non-Current Deferred Tax Liability of $22,897 in Q1 2023, down 2.1% from $23,399 a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Non-Current Deferred Tax Liability (2021 - 2023) Analysis & Trends

At the end of FY2022, Adial Pharmaceuticals reported Non-Current Deferred Tax Liability of $1,690, down 92.8% from FY2021.

  • Across earlier years, Non-Current Deferred Tax Liability came in at $23,399 in FY2021.
  • Quarterly Non-Current Deferred Tax Liability has ranged from $1,690 in Q4 2022 to $23,399 in Q3 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1,690 (Q4 2022), $23,399 (Q3 2022) and $23,399 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 22,897.00
Dec 31, 2022 1,690.00
Sep 30, 2022 23,399.00
Jun 30, 2022 23,399.00
Mar 31, 2022 23,399.00
Dec 31, 2021 23,399.00
API Access

Adial Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ADIL&period=max&api_key=YOUR_API_KEY